Next Article in Journal
Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
Next Article in Special Issue
Pyrosequencing Analysis Reveals Changes in Intestinal Microbiota of Healthy Adults Who Received a Daily Dose of Immunomodulatory Probiotic Strains
Previous Article in Journal
Impact of Leucine Supplementation on Exercise Training Induced Anti-Cardiac Remodeling Effect in Heart Failure Mice
Previous Article in Special Issue
Phylum Level Change in the Cecal and Fecal Gut Communities of Rats Fed Diets Containing Different Fermentable Substrates Supports a Role for Nitrogen as a Factor Contributing to Community Structure
Open AccessArticle

Hypolipidemic Effects and Safety of Lactobacillus Reuteri 263 in a Hamster Model of Hyperlipidemia

Graduate Institute of Athletics and Coaching Science, National Taiwan Sport University, Taoyuan 33301, Taiwan
Graduate Institute of Sports Science, National Taiwan Sport University, Taoyuan 33301, Taiwan
Center for Liberal Arts, Taipei Medical University, Taipei 11031, Taiwan
College of Exercise and Health Sciences, National Taiwan Sport University, Taoyuan 33301, Taiwan
Division of Physical Medicine and Rehabilitation, Lo-Hsu foundation, Inc., Lotung Poh-Ai Hospital, Yilan 26546, Taiwan
Department of Neurosurgery, Taipei Medical University-WanFang Hospital, Taipei 11696, Taiwan
Department of Food Science, Nutrition, and Nutraceutical Biotechnology, Shih Chien University, Taipei 10462, Taiwan
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2015, 7(5), 3767-3782;
Received: 11 March 2015 / Revised: 8 April 2015 / Accepted: 12 May 2015 / Published: 15 May 2015
(This article belongs to the Special Issue Microbiome and Human Health)
We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 109 cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect. View Full-Text
Keywords: hypolipidemic; cholesterol; triglyceride; high-cholesterol diet; lipid-lowering hypolipidemic; cholesterol; triglyceride; high-cholesterol diet; lipid-lowering
Show Figures

Figure 1

MDPI and ACS Style

Huang, W.-C.; Chen, Y.-M.; Kan, N.-W.; Ho, C.-S.; Wei, L.; Chan, C.-H.; Huang, H.-Y.; Huang, C.-C. Hypolipidemic Effects and Safety of Lactobacillus Reuteri 263 in a Hamster Model of Hyperlipidemia. Nutrients 2015, 7, 3767-3782.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop